These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 34185896)

  • 21. Evaluating the utility of therapeutic drug monitoring in the clinical use of small molecule kinase inhibitors: a review of the literature.
    Fahmy A; Hopkins AM; Sorich MJ; Rowland A
    Expert Opin Drug Metab Toxicol; 2021 Jul; 17(7):803-821. PubMed ID: 34278936
    [No Abstract]   [Full Text] [Related]  

  • 22. What Does it Take to Make Model-Informed Precision Dosing Common Practice? Report from the 1st Asian Symposium on Precision Dosing.
    Polasek TM; Rostami-Hodjegan A; Yim DS; Jamei M; Lee H; Kimko H; Kim JK; Nguyen PTT; Darwich AS; Shin JG
    AAPS J; 2019 Jan; 21(2):17. PubMed ID: 30627939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interpreting and Implementing Clinical Pharmacogenetic Tests: Perspectives From Service Providers.
    Hachad H; Ramsey LB; Scott SA
    Clin Pharmacol Ther; 2019 Aug; 106(2):298-301. PubMed ID: 31162629
    [No Abstract]   [Full Text] [Related]  

  • 24. Individualizing pharmacogenomic test results in the context of the microbiome.
    Haga SB
    Per Med; 2020 Nov; 17(6):459-468. PubMed ID: 33026284
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preemptive Panel-Based Pharmacogenetic Testing: The Time is Now.
    Weitzel KW; Cavallari LH; Lesko LJ
    Pharm Res; 2017 Aug; 34(8):1551-1555. PubMed ID: 28466392
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The scientific basis of rational prescribing. A guide to precision clinical pharmacology based on the WHO 6-step method.
    Rongen GA; Marquet P; van Gerven JMA;
    Eur J Clin Pharmacol; 2021 May; 77(5):677-683. PubMed ID: 33210160
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Point-of-Care Therapeutic Drug Monitoring for Precision Dosing of Immunosuppressive Drugs.
    Taddeo A; Prim D; Bojescu ED; Segura JM; Pfeifer ME
    J Appl Lab Med; 2020 Jul; 5(4):738-761. PubMed ID: 32533157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Individualized Patient Care Through Model-Informed Precision Dosing: Reflections on Training Future Practitioners.
    Jelliffe R; Liu J; Drusano GL; Martinez MN
    AAPS J; 2022 Nov; 24(6):117. PubMed ID: 36380020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Model-Informed Artificial Intelligence: Reinforcement Learning for Precision Dosing.
    Ribba B; Dudal S; Lavé T; Peck RW
    Clin Pharmacol Ther; 2020 Apr; 107(4):853-857. PubMed ID: 31955414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Machine Learning: A New Approach for Dose Individualization.
    Li QY; Tang BH; Wu YE; Yao BF; Zhang W; Zheng Y; Zhou Y; van den Anker J; Hao GX; Zhao W
    Clin Pharmacol Ther; 2024 Apr; 115(4):727-744. PubMed ID: 37713106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Towards precision medicine: Therapeutic drug monitoring-guided dosing of vancomycin and β-lactam antibiotics to maximize effectiveness and minimize toxicity.
    Cusumano JA; Klinker KP; Huttner A; Luther MK; Roberts JA; LaPlante KL
    Am J Health Syst Pharm; 2020 Jul; 77(14):1104-1112. PubMed ID: 32537644
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Routine Clinical use of Pharmacogenetic Tests: What it Will Require?
    Dias MM; Sorich MJ; Rowland A; Wiese MD; McKinnon RA
    Pharm Res; 2017 Aug; 34(8):1544-1550. PubMed ID: 28236061
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Personalized drug therapy based on genetics. Possibilities and examples from clinical practice].
    Stingl JC; Just KS; Kaumanns K; Schurig-Urbaniak M; Scholl C; von Mallek D; Brockmöller J
    Internist (Berl); 2016 Mar; 57(3):289-97. PubMed ID: 26830424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leveraging innovative technology to generate drug response phenotypes for the advancement of biomarker-driven precision dosing.
    Oni-Orisan A; Srinivas N; Mehta K; Das JL; Nguyen TT; Tison GH; Bauer SR; Burian M; Funk RS; Graham RA;
    Clin Transl Sci; 2021 May; 14(3):784-790. PubMed ID: 33421282
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paediatric models in motion: requirements for model-based decision support at the bedside.
    Barrett JS
    Br J Clin Pharmacol; 2015 Jan; 79(1):85-96. PubMed ID: 24251868
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Physiologically-Based Pharmacokinetic Models as Enablers of Precision Dosing in Drug Development: Pivotal Role of the Human Mass Balance Study.
    Rowland Yeo K; Venkatakrishnan K
    Clin Pharmacol Ther; 2021 Jan; 109(1):51-54. PubMed ID: 33220063
    [No Abstract]   [Full Text] [Related]  

  • 37. Variant discovery using next-generation sequencing and its future role in pharmacogenetics.
    Russell LE; Schwarz UI
    Pharmacogenomics; 2020 May; 21(7):471-486. PubMed ID: 32338137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Precision psychiatry in clinical practice.
    Zanardi R; Prestifilippo D; Fabbri C; Colombo C; Maron E; Serretti A
    Int J Psychiatry Clin Pract; 2021 Mar; 25(1):19-27. PubMed ID: 32852246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Model Averaging/Selection Approach Improves the Predictive Performance of Model-Informed Precision Dosing: Vancomycin as a Case Study.
    Uster DW; Stocker SL; Carland JE; Brett J; Marriott DJE; Day RO; Wicha SG
    Clin Pharmacol Ther; 2021 Jan; 109(1):175-183. PubMed ID: 32996120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beyond Population-Level Targets for Drug Concentrations: Precision Dosing Needs Individual-Level Targets that Include Superior Biomarkers of Drug Responses.
    Polasek TM; Peck RW
    Clin Pharmacol Ther; 2024 Sep; 116(3):602-612. PubMed ID: 38328977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.